Future Outlook And Stock Price Performance For BioAffinity Technologies Inc (NASDAQ: BIAF)

In the last trading session, 0.17 million shares of the BioAffinity Technologies Inc (NASDAQ:BIAF) were traded, and its beta was 3.03. Most recently the company’s share price was $0.68, and it changed around -$0.04 or -6.76% from the last close, which brings the market valuation of the company to $10.52M. BIAF currently trades at a discount to its 52-week high of $3.62, offering almost -432.35% off that amount. The share price’s 52-week low was $0.67, which indicates that the current value has risen by an impressive 1.47% since then. We note from BioAffinity Technologies Inc’s average daily trading volume that its 10-day average is 0.43 million shares, with the 3-month average coming to 207.79K.

BioAffinity Technologies Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended BIAF as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. BioAffinity Technologies Inc is expected to report earnings per share of -0.14 for the current quarter.

BioAffinity Technologies Inc (NASDAQ:BIAF) trade information

Instantly BIAF has showed a red trend with a performance of -6.76% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.8200 on recent trading dayincreased the stock’s daily price by 17.07%. The company’s shares are currently down -25.82% year-to-date, but still down -16.67% over the last five days. On the other hand, BioAffinity Technologies Inc (NASDAQ:BIAF) is -23.34% down in the 30-day period. We can see from the shorts that 0.27 million shares have been sold at a short interest cover period of 1.43 day(s).

Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 2.42M in revenue for the current quarter. 1 analysts expect BioAffinity Technologies Inc to make 2.62M in revenue for the current ending quarter.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -19.28%.

BIAF Dividends

BioAffinity Technologies Inc’s next quarterly earnings report is expected to be released in February.

BioAffinity Technologies Inc (NASDAQ:BIAF)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 29.55% of BioAffinity Technologies Inc shares, and 3.03% of them are in the hands of institutional investors. The stock currently has a share float of 4.29%.

Vanguard Total Stock Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 220.23 shares worth $0.15 million, making up 1.41% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 47.0 shares worth around $31727.0, which represents about 0.30% of the total shares outstanding.